in Newswire Published on May 16, 2022

Acella Pharmaceuticals Hit with Class Action Over Alleged Sale of ‘Defective’ Thyroid Medication [UPDATE]

by Corrado Rizzi

Last Updated on March 26, 2024

Faulkner v. Acella Pharmaceuticals, LLC

Filed: May 12, 2022 § 2:22-cv-00092

A proposed class action lawsuit alleges Acella Pharmaceuticals has for years falsely touted its NP Thyroid medication.





March 26, 2024 – Acella Thyroid Medication Lawsuit Settlement Website Is Live

February 20, 2024 – Acella Agrees to More Than $41M Settlement in Thyroid Medication Lawsuit

Case Spotlight

Hair Relaxer Lawsuits Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on March 26, 2024 — 9:40 AM

Corrado Rizzi

Corrado Rizzi is the Senior Managing Editor of

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.